Cargando…

Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up

Detalles Bibliográficos
Autores principales: Godinho, Iolanda, Melo, Maria João, Gonçalves, João, Neves, Marta, Santana, Alice, Oliveira Guerra, José, Gomes da Costa, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498016/
https://www.ncbi.nlm.nih.gov/pubmed/28706978
http://dx.doi.org/10.1097/TXD.0000000000000696
_version_ 1783248236235980800
author Godinho, Iolanda
Melo, Maria João
Gonçalves, João
Neves, Marta
Santana, Alice
Oliveira Guerra, José
Gomes da Costa, António
author_facet Godinho, Iolanda
Melo, Maria João
Gonçalves, João
Neves, Marta
Santana, Alice
Oliveira Guerra, José
Gomes da Costa, António
author_sort Godinho, Iolanda
collection PubMed
description
format Online
Article
Text
id pubmed-5498016
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-54980162017-07-13 Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up Godinho, Iolanda Melo, Maria João Gonçalves, João Neves, Marta Santana, Alice Oliveira Guerra, José Gomes da Costa, António Transplant Direct Letter to the Editor Lippincott Williams & Wilkins 2017-06-19 /pmc/articles/PMC5498016/ /pubmed/28706978 http://dx.doi.org/10.1097/TXD.0000000000000696 Text en Copyright © 2017 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Letter to the Editor
Godinho, Iolanda
Melo, Maria João
Gonçalves, João
Neves, Marta
Santana, Alice
Oliveira Guerra, José
Gomes da Costa, António
Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
title Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
title_full Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
title_fullStr Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
title_full_unstemmed Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
title_short Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
title_sort impact of conversion from advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study—a 3-year follow-up
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498016/
https://www.ncbi.nlm.nih.gov/pubmed/28706978
http://dx.doi.org/10.1097/TXD.0000000000000696
work_keys_str_mv AT godinhoiolanda impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup
AT melomariajoao impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup
AT goncalvesjoao impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup
AT nevesmarta impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup
AT santanaalice impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup
AT oliveiraguerrajose impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup
AT gomesdacostaantonio impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup